Immunovant (IMVT) Other Non Operating Income (2018 - 2026)
Immunovant (IMVT) posted Other Non Operating Income of $798000.0 for Q1 2026, up 1577.78% on a QoQ basis from -$54000.0 in Q4 2025, and down 25.49% year-over-year from $1.1 million in Q1 2025.
Immunovant (IMVT) Other Non Operating Income (2018 - 2026) Analysis & Trends
Immunovant's Other Non Operating Income history runs 9 years deep, the most recent figure standing at $798000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 25.49% year-over-year to $798000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 364.04% YoY) and the FY2026 annual result came in at $2.2 million, up 363.06% from the prior year.
- Other Non Operating Income was $798000.0 for Q1 2026 at Immunovant, up from -$54000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.2 million in Q2 2025 and bottomed at -$2.6 million in Q1 2024.
- A 5-year average of $84235.3 and a median of $354000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income tumbled 1441.23% — and 2025, when it soared 4139.29%.
- Immunovant's Other Non Operating Income stood at -$1.8 million in 2022, then soared by 162.27% to $1.1 million in 2023, then plunged by 214.99% to -$1.3 million in 2024, then soared by 95.71% to -$54000.0 in 2025, then soared by 1577.78% to $798000.0 in 2026.
- Business Quant data shows IMVT's Other Non Operating Income at $798000.0 in Q1 2026, -$54000.0 in Q4 2025, and $250000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 798,000.00 |
| Dec 31, 2025 | -54,000.00 |
| Sep 30, 2025 | 250,000.00 |
| Jun 30, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 629,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | -2.59 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 464,000.00 |
| Mar 31, 2023 | 356,000.00 |
| Dec 31, 2022 | -1.76 Mn |
| Sep 30, 2022 | 793,000.00 |
| Jun 30, 2022 | 354,000.00 |
| Mar 31, 2022 | 44,000.00 |
| Dec 31, 2021 | -114,000.00 |
| Sep 30, 2021 | -84,000.00 |
| Jun 30, 2021 | -626,000.00 |